Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Diagnostic Utility of the ImmunoCyt/uCyt+ Test in Bladder Cancer.

Greene KL, Berry A, Konety BR.

Rev Urol. 2006 Fall;8(4):190-7.

2.
3.

uCyt+/ImmunoCyt and cytology in the detection of urothelial carcinoma: an update on 7422 analyses.

Comploj E, Mian C, Ambrosini-Spaltro A, Dechet C, Palermo S, Trenti E, Lodde M, Horninger W, Pycha A.

Cancer Cytopathol. 2013 Jul;121(7):392-7. doi: 10.1002/cncy.21287. Epub 2013 Mar 12.

4.

The value of the ImmunoCyt/uCyt+ test in the detection and follow-up of carcinoma in situ of the urinary bladder.

Mian C, Lodde M, Comploj E, Palermo S, Mian M, Maier K, Pycha A.

Anticancer Res. 2005 Sep-Oct;25(5):3641-4.

5.

uCyt+ test: alternative to cystoscopy for less-invasive follow-up of patients with low risk of urothelial carcinoma.

Lodde M, Mian C, Comploj E, Palermo S, Longhi E, Marberger M, Pycha A.

Urology. 2006 May;67(5):950-4.

PMID:
16698355
6.

uCyt+/ImmunoCyt in the detection of recurrent urothelial carcinoma: an update on 1991 analyses.

Mian C, Maier K, Comploj E, Lodde M, Berner L, Lusuardi L, Palermo S, Vittadello F, Pycha A.

Cancer. 2006 Feb 25;108(1):60-5.

7.

Reflex ImmunoCyt testing for the diagnosis of bladder cancer in patients with atypical urine cytology.

Odisho AY, Berry AB, Ahmad AE, Cooperberg MR, Carroll PR, Konety BR.

Eur Urol. 2013 May;63(5):936-40. doi: 10.1016/j.eururo.2012.04.019. Epub 2012 Apr 14.

8.

Which urine marker test provides more diagnostic value in conjunction with standard cytology- ImmunoCyt/uCyt+ or Cytokeratin 20 expression.

Soyuer I, Sofikerim M, Tokat F, Soyuer S, Ozturk F.

Diagn Pathol. 2009 Jun 26;4:20. doi: 10.1186/1746-1596-4-20.

9.

Comparative evaluation of ProEx C and ImmunoCyt/uCyt assays in atypical urine cytology.

Vergara-Lluri ME, Hu E, Rao JY, Levin M, Apple SK, Moatamed NA.

Arch Pathol Lab Med. 2014 Sep;138(9):1215-22. doi: 10.5858/arpa.2013-0433-OA.

PMID:
25171704
10.

[Clinical usefulness of the ImmunoCyt urinary test in the follow-up protocol of patients with urothelial neoplasms].

García Peñalver C, Pérez Barrios A, Leiva Galvis O.

Actas Urol Esp. 2005 Jun;29(6):535-41. Spanish.

PMID:
16092675
11.

Diagnosis of urothelial carcinoma from urine.

Têtu B.

Mod Pathol. 2009 Jun;22 Suppl 2:S53-9. doi: 10.1038/modpathol.2008.193. Review.

12.

ImmunoCyt and cytokeratin 20 immunocytochemistry as adjunct markers for urine cytologic detection of bladder cancer: a prospective study.

Li HX, Li M, Li CL, Ma JH, Wang MR, Rao J, Pan QJ.

Anal Quant Cytol Histol. 2010 Feb;32(1):45-52.

PMID:
20701087
13.

Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer.

Toma MI, Friedrich MG, Hautmann SH, Jäkel KT, Erbersdobler A, Hellstern A, Huland H.

World J Urol. 2004 Jun;22(2):145-9. Epub 2004 Feb 27.

PMID:
14991320
14.

Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.

Pfister C, Chautard D, Devonec M, Perrin P, Chopin D, Rischmann P, Bouchot O, Beurton D, Coulange C, Rambeaud JJ.

J Urol. 2003 Mar;169(3):921-4.

PMID:
12576813
15.

Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder.

Feil G, Zumbrägel A, Päulgen-Nelde HJ, Hennenlotter J, Maurer S, Krause S, Bichler KH, Stenzl A.

Anticancer Res. 2003 Mar-Apr;23(2A):963-7.

PMID:
12820331
16.

Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.

Hautmann S, Toma M, Lorenzo Gomez MF, Friedrich MG, Jaekel T, Michl U, Schroeder GL, Huland H, Juenemann KP, Lokeshwar VB.

Eur Urol. 2004 Oct;46(4):466-71.

PMID:
15363562
17.

Performance of urine test in patients monitored for recurrence of bladder cancer: a multicenter study in the United States.

Messing EM, Teot L, Korman H, Underhill E, Barker E, Stork B, Qian J, Bostwick DG.

J Urol. 2005 Oct;174(4 Pt 1):1238-41.

PMID:
16145377
18.

Immunocyt: a new tool for detecting transitional cell cancer of the urinary tract.

Mian C, Pycha A, Wiener H, Haitel A, Lodde M, Marberger M.

J Urol. 1999 May;161(5):1486-9.

PMID:
10210378
19.

Biomarkers for detection and surveillance of bladder cancer.

Budman LI, Kassouf W, Steinberg JR.

Can Urol Assoc J. 2008 Jun;2(3):212-21.

20.

[Value of the uCyt+ test for the detection and followup of bladder tumors].

Drapier E, Renaudin K, Maillet F, Braud G, Laboisse C, Bouchot O.

Prog Urol. 2003 Apr;13(2):222-6. French.

PMID:
12765055

Supplemental Content

Support Center